Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.

Waid DM, Wagner RJ, Putnam A, Vaitaitis GM, Pennock ND, Calverley DC, Gottlieb P, Wagner DH Jr.

Clin Immunol. 2007 Aug;124(2):138-48. Epub 2007 Jun 8.

PMID:
17560173
[PubMed - indexed for MEDLINE]
2.

At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction.

Glisic-Milosavljevic S, Waukau J, Jailwala P, Jana S, Khoo HJ, Albertz H, Woodliff J, Koppen M, Alemzadeh R, Hagopian W, Ghosh S.

PLoS One. 2007 Jan 3;2(1):e146.

PMID:
17206281
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 Type 1 diabetes.

Durinovic-Belló I, Schlosser M, Riedl M, Maisel N, Rosinger S, Kalbacher H, Deeg M, Ziegler M, Elliott J, Roep BO, Karges W, Boehm BO.

Diabetologia. 2004 Mar;47(3):439-50. Epub 2004 Jan 24.

PMID:
14745491
[PubMed - indexed for MEDLINE]
4.

Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes.

Preda I, McEvoy RC, Lin M, Bona CA, Rapaport R, Brumeanu TD, Casares S.

Eur J Immunol. 2005 Sep;35(9):2762-75.

PMID:
16106371
[PubMed - indexed for MEDLINE]
5.

CD40 engagement of CD4+ CD40+ T cells in a neo-self antigen disease model ablates CTLA-4 expression and indirectly impacts tolerance.

Carter J, Vaitaitis GM, Waid DM, Wagner DH Jr.

Eur J Immunol. 2012 Feb;42(2):424-35. doi: 10.1002/eji.201141880.

PMID:
22105491
[PubMed - indexed for MEDLINE]
6.

Genetic association of HLA DQB1 with CD4+CD25+(high) T-cell apoptosis in type 1 diabetes.

Glisic S, Klinker M, Waukau J, Jailwala P, Jana S, Basken J, Wang T, Alemzadeh R, Hagopian W, Ghosh S.

Genes Immun. 2009 Jun;10(4):334-40. doi: 10.1038/gene.2009.14. Epub 2009 Mar 19.

PMID:
19295543
[PubMed - indexed for MEDLINE]
7.

Switch from a dominant Th1-associated immune profile during the pre-diabetic phase in favour of a temporary increase of a Th3-associated and inflammatory immune profile at the onset of type 1 diabetes.

Ryden A, Stechova K, Durilova M, Faresjö M.

Diabetes Metab Res Rev. 2009 May;25(4):335-43. doi: 10.1002/dmrr.958.

PMID:
19382103
[PubMed - indexed for MEDLINE]
8.

Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects.

Danke NA, Yang J, Greenbaum C, Kwok WW.

J Autoimmun. 2005 Dec;25(4):303-11. Epub 2005 Oct 24.

PMID:
16249070
[PubMed - indexed for MEDLINE]
9.

CD 127- and FoxP3+ expression on CD25+CD4+ T regulatory cells upon specific diabetogeneic stimulation in high-risk relatives of type 1 diabetes mellitus patients.

Vrabelova Z, Hrotekova Z, Hladikova Z, Bohmova K, Stechova K, Michalek J.

Scand J Immunol. 2008 Apr;67(4):404-10. doi: 10.1111/j.1365-3083.2008.02074.x. Epub 2008 Feb 1.

PMID:
18248531
[PubMed - indexed for MEDLINE]
10.

Peripheral CD4loCD40+ auto-aggressive T cell expansion during insulin-dependent diabetes mellitus.

Waid DM, Vaitaitis GM, Wagner DH Jr.

Eur J Immunol. 2004 May;34(5):1488-97.

PMID:
15114683
[PubMed - indexed for MEDLINE]
11.

Reduced CCR4, interleukin-13 and GATA-3 up-regulation in response to type 2 cytokines of cord blood T lymphocytes in infants at genetic risk of type 1 diabetes.

Luopajärvi K, Skarsvik S, Ilonen J, Akerblom HK, Vaarala O.

Immunology. 2007 Jun;121(2):189-96. Epub 2007 Jan 18.

PMID:
17244154
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope.

Kent SC, Chen Y, Bregoli L, Clemmings SM, Kenyon NS, Ricordi C, Hering BJ, Hafler DA.

Nature. 2005 May 12;435(7039):224-8.

PMID:
15889096
[PubMed - indexed for MEDLINE]
Free Article
13.

Role of regulatory T cells for the treatment of type 1 diabetes mellitus.

Jaeckel E, Mpofu N, Saal N, Manns MP.

Horm Metab Res. 2008 Feb;40(2):126-36. doi: 10.1055/s-2008-1042427. Review.

PMID:
18283631
[PubMed - indexed for MEDLINE]
14.

Expression levels of CXC chemokine receptors 3 are associated with clinical phenotype of type 1 diabetes.

Yamada S, Oikawa Y, Sakai G, Atsumi Y, Maruyama T, Shimada A.

Ann N Y Acad Sci. 2006 Oct;1079:186-9.

PMID:
17130553
[PubMed - indexed for MEDLINE]
15.

Autoimmune mechanisms in type 1 diabetes.

Knip M, Siljander H.

Autoimmun Rev. 2008 Jul;7(7):550-7. doi: 10.1016/j.autrev.2008.04.008. Epub 2008 Apr 30. Review.

PMID:
18625444
[PubMed - indexed for MEDLINE]
16.

Immune regulatory T cells in siblings of children suffering from type 1 diabetes mellitus.

Michalek J, Vrabelova Z, Hrotekova Z, Kyr M, Pejchlova M, Kolouskova S, Faresjö M, Stechova K.

Scand J Immunol. 2006 Nov;64(5):531-5.

PMID:
17032246
[PubMed - indexed for MEDLINE]
17.

Impaired CD4 and CD8 T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children.

Hedman M, Faresjö M, Axelsson S, Ludvigsson J, Casas R.

Clin Exp Immunol. 2008 Sep;153(3):360-8. doi: 10.1111/j.1365-2249.2008.03720.x.

PMID:
18803760
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Autoreactive T cells in healthy individuals.

Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW.

J Immunol. 2004 May 15;172(10):5967-72.

PMID:
15128778
[PubMed - indexed for MEDLINE]
Free Article
19.

CD40 on NOD CD4 T cells contributes to their activation and pathogenicity.

Baker RL, Wagner DH Jr, Haskins K.

J Autoimmun. 2008 Dec;31(4):385-92. doi: 10.1016/j.jaut.2008.09.001. Epub 2008 Oct 31.

PMID:
18951762
[PubMed - indexed for MEDLINE]
20.

GAD-reactive T cells were mainly detected in autoimmune-related type 1 diabetic patients with HLA DR9.

Itoh A, Shimada A, Kodama K, Morimoto J, Suzuki R, Oikawa Y, Irie J, Nakagawa Y, Shigihara T, Kanazawa Y, Okubo Y, Motohashi Y, Maruyama T, Saruta T.

Ann N Y Acad Sci. 2004 Dec;1037:33-40.

PMID:
15699491
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk